Breaking News Instant updates and real-time market news.

TSLA

Tesla

$305.33

-30.13 (-8.98%)

, ORCL

Oracle

$48.36

0.25 (0.52%)

07:30
08/20/18
08/20
07:30
08/20/18
07:30

Unusual put flow in option market yesterday

Notable put activity was cited Friday in Tesla (TSLA), Oracle (ORCL), Symantec (SYMC), Geron (GERN), L Brands (LB), NRG Energy (NRG), Foot Locker (FL), TiVo (TIVO), and AngloGold (AU).

TSLA

Tesla

$305.33

-30.13 (-8.98%)

ORCL

Oracle

$48.36

0.25 (0.52%)

SYMC

Symantec

$19.46

0.135 (0.70%)

GERN

Geron

$3.91

-0.045 (-1.14%)

LB

L Brands

$32.54

0.44 (1.37%)

NRG

NRG Energy

$33.95

0.16 (0.47%)

FL

Foot Locker

$50.69

0.95 (1.91%)

TIVO

TiVo

$12.20

-0.55 (-4.31%)

AU

AngloGold

$7.22

0.055 (0.77%)

  • 23

    Aug

  • 24

    Aug

  • 04

    Sep

  • 12

    Sep

  • 29

    Oct

TSLA Tesla
$305.33

-30.13 (-8.98%)

08/16/18
BERN
08/16/18
NO CHANGE
Target $325
BERN
Tesla price target raised to $325 after 'taking company private' tweet at Bernstein
Bernstein analyst A.M. Sacconaghi, Jr. raised his price target for Tesla to $325 after Elon Musk shocked investors last week when he tweeted that he was considering a take-private transaction for Tesla at $420 per share, and given the fact that it has been over a year since the analyst last adjusted his price target. Sacconaghi sees the odds of a successful take-private transaction at less than 50%, with downside to about $300 and upside to approximately $400.
08/15/18
VERT
08/15/18
NO CHANGE
VERT
Sell
Goldman involvement with Tesla 'doesn't mean anything,' says Vertical Research
Vertical Research analyst Gordon Johnson said Goldman Sachs (GS) being confirmed as a financial advisor to Tesla's (TSLA) proposed go-private offer "does not mean anything" beyond the "superficial optics" of the carmaker being able to "use Goldman's prestigious name to lend credence to the deal." Goldman is "in it for M&A fees" and agreeing to be an advisor is "not based on any inherent understanding of Tesla's value proposition, nor is it based on Goldman's confidence in Tesla's legal situation with respect to its significant issues surrounding disclosures and SEC involvement," according to Johnson, who maintains a Sell rating on Tesla shares.
08/15/18
VERT
08/15/18
NO CHANGE
Target $88
VERT
Sell
Vertical Research says Model 3 demand 'collapsing,' Tesla unlikely to go private
Vertical Research analyst Gordon Johnson, who has had a Sell rating on Tesla since initiating coverage of the stock in April of this year, said in a note to investors earlier that he views Elon Musk's go-private proposition as a "distraction" from what appear to be several signs of "collapsing" demand for the Model 3. Among the signs of disappointing demand he points to are "thousands of M3s are being sighted in parking lots across CA"; data from Second Measure that points to no surge in configurations when Tesla opened up M3s to the general public; data showing that demand in Norway, Tesla's third largest market, was its "weakest ever" in July; and demand crashing in China and Canada due to car import tariffs and cutting of a subsidy, respectively. Noting that Lehman Brothers had floated the idea of being taken private in 2008, Johnson said that once any potential buyer gets into Tesla's books "the prospect of a $40bn-$50bn investment will evaporate" similar to what happened to the troubled bank. Johnson maintains a Sell rating with an $88 price target on Tesla shares.
08/16/18
EVER
08/16/18
NO CHANGE
Target $301
EVER
In Line
After visiting Tesla's Freemont facility, Evercore ISI says Model 3 'on track'
Evercore ISI analyst George Galliers said he is a bit more positive on Tesla following his trip to the company's Freemont facility, stating that Tesla "seems well on the way" to achieving steady production of 5,000 to 6,000 Model 3 units per week and that reaching 7,000 to 8,000 units per week seems "well within reach." Following the trip, he said the Model 3 looks to be "on track" and while he continues to forecast second half Model 3 production of 123,000 units, Galliers now believes his estimate could be 4%-7% too low. He maintains an In Line rating on Tesla shares with a $301 price target.
ORCL Oracle
$48.36

0.25 (0.52%)

07/03/18
LEHM
07/03/18
NO CHANGE
Target $58
LEHM
Overweight
Oracle valuation remains attractive on fundamentals, says Barclays
Barclays analyst Raimo Lenschow, while acknowledging current investor skepticism for the name, says Oracle's current valuation remains attractive given its underlying fundamentals. The analyst believes, however, that Oracle "will remain in the penalty box in the near to mid-term" as investors digest the reporting structure changes and wait for additional metrics in lieu of the condensed financial reporting. Nonetheless, Lenschow continues to see upside in the shares and reiterates an Overweight rating with a $58 price target.
08/09/18
UBSW
08/09/18
NO CHANGE
Target $51
UBSW
Neutral
Oracle price target raised to $51 from $48 at UBS
UBS analyst Jennifer Lowe raised her price target on Oracle to $51 from $48 following the release of its Autonomous Database for transactional workloads. She believes this will likely be a focus for Oracle bulls and her channel checks have generally been positive on the product. The analyst remains cautious on the longer-term secular threats, but also sees the potential for positive product commentary. Lowe maintained her Neutral rating on Oracle shares.
07/25/18
JEFF
07/25/18
NO CHANGE
Target $61
JEFF
Buy
Oracle EPS target cut at Jefferies on reduced license revenue
Jefferies analyst John DiFucci kept his Buy rating and $61 price target on Oracle but lowered his FY19 EPS target to $3.34 from $3.42. The analyst notes that he is updating his model based on the new ASC 606 accounting standard, and the changes in his valuation model are driven by modestly reduced license revenue due to the requirement to recognize declining term license upfront. DiFucci contends that this requirement translates negatively to the bottom line.
06/22/18
FBCO
06/22/18
NO CHANGE
Target $150
FBCO
Neutral
Red Hat results, guidance 'disappointing,' says Credit Suisse
Credit Suisse analyst Brad Zelnick maintained a Neutral rating and $150 price target on Red Hat (RHT) after the company's "disappointing" Q1 results and lowered FY19 guidance. Unlike recent disappointments in Oracle (ORCL), Adobe (ADBE) and Workday (WKDAY), Zelnick said he believes this event may be too difficult to dismiss as a "harbinger of deceleration in enterprise IT spend."
SYMC Symantec
$19.46

0.135 (0.70%)

05/16/18
GSCO
05/16/18
DOWNGRADE
GSCO
Neutral
Symantec downgraded to Neutral from Buy at Goldman Sachs
05/15/18
JEFF
05/15/18
UPGRADE
Target $22
JEFF
Hold
Symantec upgraded to Hold from Underperform at Jefferies
Jefferies analyst John DiFucci upgraded Symantec to Hold and raised his price target for the shares to $22 from $20. While difficult, if not impossible, to assess the outcome of the current investigation, there's a base value for the business that is not far from the current price, DiFucci tells investors in a research note. He points out, however, that it "remains unclear whether the company will return to growth."
05/15/18
DBAB
05/15/18
NO CHANGE
Target $22
DBAB
Hold
Symantec call lessened near-term risk, says Deutsche Bank
The belated Q&A call hosted by Symantec, where management said they are not expecting a material adverse impact on the company's financials from the audit investigation, lessened the near-term risk, Deutsche Bank analyst Karl Keirstead tells investors in a research note. The analyst believes, however, that the audit probe risk will linger. Nonetheless, he concludes that the debate will now pivot to the likelihood of Symantec hitting "what looks like aggressive" fiscal 2020 targets. Keirstead keeps a Hold rating on the shares with a $22 price target.
05/16/18
05/16/18
DOWNGRADE
Target $24.5

Neutral
Symantec downgraded to Neutral, another transition year ahead, says Goldman
As previously reported, Goldman downgraded Symantec to Neutral from Buy with a $24.50 price target. Analyst Gabriela Borges expects FY19 to be another transition year with respect to investments, product mix and competitive positioning, compounded by an overhang in the stocks multiple from the May 10 audit investigation.
GERN Geron
$3.91

-0.045 (-1.14%)

07/05/18
RILY
07/05/18
INITIATION
Target $5.75
RILY
Buy
Geron initiated with a Buy at B. Riley FBR
B. Riley FBR analyst George Zavoico started Geron with a Buy rating and $5.75 price target.
03/19/18
PIPR
03/19/18
NO CHANGE
Target $7
PIPR
Overweight
Geron price target raised to $7 from $5 at Piper Jaffray
Piper Jaffray analyst Charles Duncan raised his price target for Geron to $7 after the company this morning reported year-end 2017 cash of $109M and provided an update on its IMerge and IMbark studies. The analyst projects the current cash will fund Geron's operations into 2020. He's encouraged by the update on the IMbark study in myelofibrosis and reiterates an Overweight rating on the shares.
LB L Brands
$32.54

0.44 (1.37%)

08/10/18
WEDB
08/10/18
INITIATION
Target $33
WEDB
Neutral
L Brands initiated with a Neutral at Wedbush
Wedbush analyst Jen Redding initiated shares of L Brands with a Neutral rating and $33 price target, telling investors that she views L Brands as a compelling story and that its management team is focused on "the right key initiatives" to drive meaningful multi-year runway ahead. She says she is initiating on the sidelines, however, due to mixed performance with strength at Bath and Body Works offset by increased competitive pressures dragging on Victoria's Secret.
08/09/18
LOOP
08/09/18
NO CHANGE
Target $27
LOOP
Sell
Loop Capital keeps Sell rating on L Brands after July update
Loop Capital analyst Laura Champine said L Brands' flat same-store sales growth missed consensus estimates in July and did so with weaker merchandise margins. She also noted that Victoria's Secret reported a 4% same-store sales decline despite heavy promotions. The analyst, who is concerned that Victoria's Secret's marketing, size limits, price range, and aesthetics are out of touch with changing consumer preferences, keeps a Sell rating and $27 price target on L Brands shares.
07/25/18
JEFF
07/25/18
NO CHANGE
Target $33
JEFF
Buy
Jefferies sees Aerie hitting $2B-$3B in sales, ups American Eagle target
American Eagle's (AEO) Aerie has the potential to be a greater than $1.5B brand over the next few years and research $2B-$3B in revenue over the long term, Jefferies analyst Janine Stichter tells investors in a research note. The analyst sees Aerie reaching 30% of American Eagle revenue in the next few years and 40% longer term. This will help drive American Eagle shares higher while adding pressure to L Brands (LB), Stichter contends. She believes recent American Eagle management commentary suggests increasing confidence in the Aerie concept. The analyst raised her price target for the shares to $33 from $30 and reiterates a Buy rating on the name.
07/25/18
JEFF
07/25/18
NO CHANGE
Target $23
JEFF
Underperform
L Brands bondholders 'slowly waking up to the reality,' says Jefferies
The credit default swaps of L Brands (LB) are rising since late May as new data points "have confirmed" the company's "monopoly is under assault," Jefferies analyst Randal Konik tells investors in a research note. Bondholders are "slowly waking up to the reality" that Victoria's Secret is "broken," PINK is "breaking," and Bed Bath & Beyond is "peaking," Konik adds. He believes rising CDS and falling bond prices indicate L Brands' debt "may lose its reputation as a complacent long." The analyst continues to believe American Eagle's (AEO) Aerie's market share gains have been a key driver of PINK's deterioration. He reiterates an Underperform rating on L Brands with a $23 price target.
NRG NRG Energy
$33.95

0.16 (0.47%)

08/06/18
SBSH
08/06/18
UPGRADE
SBSH
Buy
NRG Energy upgraded to Buy from Neutral at Citi
05/23/18
BOFA
05/23/18
INITIATION
Target $37
BOFA
Buy
NRG Energy resumed with a Buy, $37 target at BofA/Merrill
BofA/Merrill analyst Julien Dumoulin-Smith resumed coverage of NRG Energy with a Buy rating and $37 price target. The analyst notes NRG's $500M convertible debt note was paired with the completion of a "meaningful portion" of the company's $500M repurchase program, half the $1B expected in 2018. Execution of these buybacks will likely lift the share price in the near-term, Dumoulin-Smith tells investors in a research note. The analyst sees "meaningful upside" in NRG shares as Electric Reliability Council of Texas forwards "continue to climb" in 2018 and 2019.
07/30/18
SBSH
07/30/18
DOWNGRADE
Target $33
SBSH
Neutral
NRG Energy downgraded to Neutral from Buy at Citi
Citi analyst Praful Mehta downgraded NRG Energy to Neutral while raising his price target for the shares to $33 from $20. The analyst cites valuation for the downgrade but continues to like NRG's business model and low leverage.
08/06/18
SBSH
08/06/18
UPGRADE
Target $38
SBSH
Buy
Citi brings NRG Energy back to Buy a week after downgrade
Citi analyst Praful Mehta upgraded NRG Energy to Buy from Neutral and raised his price target for the shares to $38 from $33. The analyst downgraded the shares to Neutral on July 30. In a research note partially titled "We Were Wrong. Story Stronger," Mehta says the strength of NRG's model was shown in last week's Q2 report. The analyst boosted his 2019 EBITDA estimate by $300M and 2020 estimate by $150M. He views his sum-of-the-parts valuation of $38 per share as conservative since it includes no value for buybacks or return on excess cash. NRG's "strong execution and ERCOT tightness" drives the upgrade back to Buy, Mehta tells investors in a research note.
FL Foot Locker
$50.69

0.95 (1.91%)

08/16/18
OTRG
08/16/18
UPGRADE
OTRG
Positive
Foot Locker upgraded to Positive from Mixed at OTR Global
08/16/18
08/16/18
UPGRADE

Positive
Foot Locker upgraded to Positive following checks at OTR Global
As previously reported, OTR Global upgraded Foot Locker (FL) to Positive from Mixed. The firm's checks indicate Foot Locker's Q2 sales improved driven by robust demand for Nike (NKE) premium product. OTR now sees combined Q2 segment same-store-sales up 3% year-over-year, versus Q1 of flat-down 3% with combined ticket average up year-over-year with most managers surveyed.
08/17/18
ADAM
08/17/18
NO CHANGE
Target $66
ADAM
Buy
Canaccord still positive long-term on Foot Locker despite headwinds seen in Q2
Canaccord analyst Camilo Lyon previewed Foot Locker's Q2 results and he believes near-term headwinds persisted during the quarter. The analyst believes the company needs to get past the Jordan and strong upcoming European comps, before the shares can resume their upward move. He notes European comps get easier in Q3 and he believes the Jordan sales have stabilized leading to positive second half results. Lyon reiterated his Buy rating and $66 price target on Foot Locker shares.
08/20/18
DBAB
08/20/18
NO CHANGE
Target $175
DBAB
Buy
Deutsche Bank says 'sticking with' off-price, athletic brands in apparel space
Deutsche Bank analyst Paul Trussell previewed earnings for apparel companies, telling investors in a research note that he is "sticking with" off-price, the brands and athletic brands over specialty retailers and department stores. Trussell expects beats from Burlington Stores (BURL), Ross Stores (ROST), TJX (TJX), PVH (PVH), Foot Locker (FL) and Lululemon (LULU), along with American Eagle Outfitters (AEO) and Buckle (BKE) as the outliers in the specialty group and Kohl's (KSS), and says he is "a bit more cautious" for the frest of his apparel coverage given stretched valuations. Trussell raised his price target for Burlington Stores to $175 from $167, to $96 from $91 for Ross and to $105 from $100 fro TJX, but cut his price target to $171 from $176 for PVH.
TIVO TiVo
$12.20

-0.55 (-4.31%)

08/09/18
JPMS
08/09/18
NO CHANGE
Target $18
JPMS
Overweight
TiVo price target lowered to $18 from $30 at JPMorgan
JPMorgan analyst Sterling Auty lowered his price target for TiVo to $18 following the company's Q2 results but keeps an Overweight rating on the name. The analyst is "very encouraged" by the update from interim CEO Raghu Rau regarding the strategic review. The options laid out appear to make it clear that there are a couple different opportunities for shareholder value creation that potentially include breaking apart the products and intellectual property businesses to maximize the monetization potential, Auty tells investors in a post-earnings research note. He also believes TiVo pausing its search for a new CEO suggests that an outcome could take place near term.
07/06/18
BWSF
07/06/18
NO CHANGE
Target $25
BWSF
Strong Buy
TiVo could bring on CEO via acquisition, says BWS Financial
While a CEO change "usually implies being prone to a takeover," TiVo "could look to do an acquisition to bring on a CEO" after Enrique Rodriguez resigned just six months into the role, BWS Financial analyst Hamed Khorsand tells investors in a research note. The strategic options TiVo is considering "creates a wide array of options for the imaginative investor," the analyst adds. He believes the greatest overhang on TiVo shares remains the lack of annual guidance and no real set goal of what free cash flow could look like this year. Khorsand sees options for the company and keeps a Buy rating on the shares with a $25 price target.
07/05/18
JPMS
07/05/18
NO CHANGE
JPMS
Overweight
TiVo CEO exit may be viewed as 'double edged sword,' says JPMorgan
JPMorgan analyst Sterling Auty says news of TiVo CEO Enrique Rodriguez stepping down "can be perceived as a double edged sword." On one hand, investors might perceive the transition as negative for the company's strategic review process given Rodriguez's expertise in intellectual property licensing and that his compensation structure was tied much to the performance of the stock price, Auty tells investors in a research note. On the other hand, some investors might perceive the transition as an indication that there may not be a need for a CEO post, a positive outcome of the strategic review process in terms of a possible sale of the company, the analyst adds. Shares of TiVo are down 4% to $13.30 in morning trading. Auty admits, however, that the timing of Rodriguez's departure is unusual and that it is hard to read what the possible implications are in terms of the strategic review process without more information. He has an Overweight rating on TiVo shares.
07/25/18
JPMS
07/25/18
NO CHANGE
JPMS
Overweight
Invalidated patent 'not material' to TiVo court fight, says JPMorgan
JPMorgan analyst Sterling Auty noted that the USPTO's Patent Trial and Appeal Board has declared patent 8,433,696 held by TiVo (TIVO) to be invalid as it believes that the technology involves a variation of earlier know-how. While a "scary headline," the reality is this does not matter in terms of TiVo's court case with Comcast (CMCSA), since this patent was dropped from the case, said Auty, who keeps an Overweight rating on TiVo shares.
AU AngloGold
$7.22

0.055 (0.77%)

04/11/18
DBAB
04/11/18
DOWNGRADE
DBAB
Sell
Harmony Gold downgraded to Sell from Hold at Deutsche Bank
Deutsche Bank analyst Patrick Mann downgraded Harmony Gold (HMY) to Sell citing the recent rally in the shares. He lowered his price target for the shares to R18ps from R21ps. The analyst believes the mostly debt funded acquisition of Moab Khotsong and a 7% lower Rand-Gold price compared to 12 months ago creates downside risk for the shares. Mann is neutral on the sector but continues to favor "geographically diversified" producers AngloGold (AU) and Gold Fields (GFI).
11/30/17
DBAB
11/30/17
NO CHANGE
DBAB
Deutsche upgrades three gold producers after changing rand forecast
Deutsche Bank analyst Patrick Mann upgraded three South African gold producers after adjusting his rand forecasts by an average of 13% over 2018-2023. For 2018, the analyst uses a rand 14.22 to one U.S. dollar ratio, which boosts his rand-based price targets for the shares by an average 27%. Mann upgraded both AngloGold (AU) and Gold Fields (GFI) to Buy from Hold. He sees the companies returning to positive free cash flow in 2018. The analyst also upgraded Harmony Gold (HMY) to Hold from Sell.
11/30/17
DBAB
11/30/17
UPGRADE
DBAB
Buy
AngloGold upgraded to Buy from Hold at Deutsche Bank
11/13/17
RBCM
11/13/17
UPGRADE
Target $11.5
RBCM
Outperform
AngloGold upgraded to Outperform from Sector Perform at RBC Capital
RBC Capital analyst Richard Hatch upgraded AngloGold Ashanti to Outperform from Sector Perform and raised his price target to ZAR17,000 from ZAR15,600. Hatch notes the release of a rebase plan for Obuasi, the successful disposal of higher-cost South African mines, and the ramp at its Kibali site among the potential upside catalysts for the company, saying he anticipates an increase in free cash flow amid a sustaining drop in capital expenditure.

TODAY'S FREE FLY STORIES

02:50
05/23/19
05/23
02:50
05/23/19
02:50
General news
FX Update: The main currencies have traded with limited directional bias »

FX Update: The main…

BCYC

Bicycle Therapeutics

$0.00

(0.00%)

21:58
05/22/19
05/22
21:58
05/22/19
21:58
Syndicate
Bicycle Therapeutics 4.333M share IPO priced at $14.00 »

The deal priced at the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

IDYA

IDEAYA Biosciences

$0.00

(0.00%)

21:36
05/22/19
05/22
21:36
05/22/19
21:36
Syndicate
IDEAYA Biosciences 5M share IPO priced at $10.00 »

The deal priced below the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

MDT

Medtronic

$89.02

1.22 (1.39%)

, HRL

Hormel Foods

$39.48

-0.33 (-0.83%)

20:25
05/22/19
05/22
20:25
05/22/19
20:25
Earnings
Notable companies reporting before tomorrow's open »

Notable companies…

MDT

Medtronic

$89.02

1.22 (1.39%)

HRL

Hormel Foods

$39.48

-0.33 (-0.83%)

BBY

Best Buy

$69.26

-0.68 (-0.97%)

BJ

BJ's Wholesale

$26.50

0.94 (3.68%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 28

    May

  • 29

    May

  • 29

    May

  • 30

    May

  • 11

    Jun

  • 20

    Jun

HFC

HollyFrontier

$42.69

-1.45 (-3.29%)

20:19
05/22/19
05/22
20:19
05/22/19
20:19
Periodicals
Breaking Periodicals news story on HollyFrontier »

HollyFrontier to shut…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PS

Pluralsight

$33.43

-0.58 (-1.71%)

, MSFT

Microsoft

$127.67

0.77 (0.61%)

20:04
05/22/19
05/22
20:04
05/22/19
20:04
Recommendations
Pluralsight, Microsoft analyst commentary at First Analysis »

Meetings with Pluralsight…

PS

Pluralsight

$33.43

-0.58 (-1.71%)

MSFT

Microsoft

$127.67

0.77 (0.61%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 03

    Jun

  • 03

    Jun

  • 08

    Jun

  • 10

    Jun

  • 11

    Jun

  • 23

    Jun

  • 06

    Aug

GTE

Gran Tierra

$2.09

-0.03 (-1.42%)

19:28
05/22/19
05/22
19:28
05/22/19
19:28
Hot Stocks
Gran Tierra confirms award of 3 Ecuador blocks with 140K acre total area »

Gran Tierra announces…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

PGR

Progressive

$80.47

0.44 (0.55%)

19:10
05/22/19
05/22
19:10
05/22/19
19:10
Hot Stocks
Progressive's Sieger sells 7,500 common shares »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CRM

Salesforce

$157.60

1.83 (1.17%)

19:05
05/22/19
05/22
19:05
05/22/19
19:05
Hot Stocks
Salesforce Ventures launches $125M Europe Trailblazer Fund »

Salesforce announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 04

    Jun

  • 06

    Jun

  • 23

    Jun

MRCY

Mercury Systems

$70.96

0.08 (0.11%)

19:05
05/22/19
05/22
19:05
05/22/19
19:05
Syndicate
Mercury Systems 6M share Secondary priced at $69.00 »

The deal size was…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

  • 23

    May

RNG

RingCentral

$122.58

0.14 (0.11%)

18:57
05/22/19
05/22
18:57
05/22/19
18:57
Hot Stocks
RingCentral CEO: We have an all in one solution for business communications »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 28

    May

  • 05

    Jun

  • 13

    Nov

LB

L Brands

$24.29

1.605 (7.08%)

, VIPS

Vipshop

$7.75

0.095 (1.24%)

18:53
05/22/19
05/22
18:53
05/22/19
18:53
Hot Stocks
Fly Intel: After Hours Movers »

UP AFTER EARNINGS: L…

LB

L Brands

$24.29

1.605 (7.08%)

VIPS

Vipshop

$7.75

0.095 (1.24%)

CPRT

Copart

$64.99

-0.91 (-1.38%)

CTRP

Ctrip

$37.78

-0.09 (-0.24%)

SNPS

Synopsys

$115.10

-0.63 (-0.54%)

AVP

Avon Products

$4.07

0.875 (27.39%)

GILD

Gilead

$67.25

0.73 (1.10%)

IOVA

Iovance Biotherapeutics

$17.71

1.5 (9.25%)

AMGN

Amgen

$173.23

3.61 (2.13%)

NTAP

NetApp

$62.58

-7.43 (-10.61%)

SCVL

Shoe Carnival

$29.65

-2.6 (-8.06%)

HTHT

Huazhu Group

$34.41

-0.47 (-1.35%)

SBLK

Star Bulk Carriers

$8.13

-0.13 (-1.57%)

ONVO

Organovo

$0.78

-0.158 (-16.84%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 22

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 23

    May

  • 31

    May

  • 03

    Jun

  • 06

    Jun

  • 10

    Jun

  • 10

    Jun

  • 13

    Jun

  • 09

    Jul

  • 16

    Jul

  • 17

    Jul

  • 26

    Sep

  • 27

    Sep

HMC

Honda

$25.54

-0.17 (-0.66%)

, TKTDY

Takata

$0.00

(0.00%)

18:53
05/22/19
05/22
18:53
05/22/19
18:53
Hot Stocks
Honda to recall about 19,000 vehicles in the U.S. over faulty inflator kits »

Honda (HMC) will…

HMC

Honda

$25.54

-0.17 (-0.66%)

TKTDY

Takata

$0.00

(0.00%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

DSNKY

Daiichi Sankyo

$0.00

(0.00%)

18:39
05/22/19
05/22
18:39
05/22/19
18:39
Periodicals
Breaking Periodicals news story on Daiichi Sankyo »

Daiichi Sankyo in talks…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 31

    May

SPOT

Spotify

$127.10

-5.06 (-3.83%)

18:27
05/22/19
05/22
18:27
05/22/19
18:27
Periodicals
Spotify resets some users' passwords over 'suspicious activity,' TechCrunch says »

Spotify has informed an…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

IDXX

Idexx Laboratories

$250.45

1.24 (0.50%)

18:20
05/22/19
05/22
18:20
05/22/19
18:20
Hot Stocks
Idexx Laboratories CEO: We're at the beginning of our runway for growth »

In an interview on…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 05

    Jun

OMC

Omnicom

$79.79

-0.3 (-0.37%)

18:15
05/22/19
05/22
18:15
05/22/19
18:15
Hot Stocks
Omnicom CEO sells 60.5K shares of common stock »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BSX

Boston Scientific

$37.74

0.04 (0.11%)

18:12
05/22/19
05/22
18:12
05/22/19
18:12
Hot Stocks
Boston Scientific initiates trial of WATCHMAN FLX appendage closure platform »

Boston Scientific has…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 29

    May

  • 26

    Jun

  • 13

    Nov

CTRP

Ctrip

$37.63

-0.24 (-0.63%)

18:03
05/22/19
05/22
18:03
05/22/19
18:03
Hot Stocks
Ctrip reports Q1 gross margin 79% vs. 82% a year ago »

Remained consistent with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CTRP

Ctrip

$37.63

-0.24 (-0.63%)

18:02
05/22/19
05/22
18:02
05/22/19
18:02
Earnings
Breaking Earnings news story on Ctrip »

Ctrip sees Q2 net revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CTRP

Ctrip

$37.63

-0.24 (-0.63%)

18:01
05/22/19
05/22
18:01
05/22/19
18:01
Earnings
Ctrip reports Q1 adjusted EPS 44c, consensus 24c »

Reports Q1 revenue $1.2B,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 23

    May

CE

Celanese

$100.10

-0.18 (-0.18%)

18:01
05/22/19
05/22
18:01
05/22/19
18:01
Hot Stocks
Celanese announces acetyls product price increases »

Celanese Corporation will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

XRAY

Dentsply Sirona

$54.64

-0.25 (-0.46%)

17:57
05/22/19
05/22
17:57
05/22/19
17:57
Hot Stocks
Dentsply Sirona CFO Alexos to leave company in connection with relocation »

In a regulatory filing,…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 22

    May

  • 05

    Jun

SIM

Grupo Simec

$9.23

(0.00%)

17:55
05/22/19
05/22
17:55
05/22/19
17:55
Hot Stocks
Grupo Simec receives noncompliance notification from NYSE »

Grupo Simec announced…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

CPRT

Copart

$64.78

-1.12 (-1.70%)

17:51
05/22/19
05/22
17:51
05/22/19
17:51
Earnings
Copart reports Q3 adjusted EPS 66c, consensus 62c »

Reports Q3 revenue…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 23

    May

  • 03

    Jun

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.